{"url_path":"/sec/rgnx/8-k/2026-05-14/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1590877/0001193125-26-222768-index.html","accession_number":"0001193125-26-222768","cik":"0001590877","ticker":"RGNX","issuer_name":"REGENXBIO Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1590877/0001193125-26-222768-index.html","primary_entity_key":"0001590877","primary_entity_name":"REGENXBIO Inc."},"word_count":102,"has_tables":true,"body_markdown":"Item 9.01. Financial Statements and Exhibits.\n\n(d) Exhibits\n\nExhibit No.\n\nDescription\n\n99.1\n\n[Press release dated May 14, 2026 relating to REGENXBIO Inc.’s financial results.](rgnx-ex99_1.htm)\n\n99.2\n\n \n\n[RGX-202 Press Release dated May 14, 2026.](rgnx-ex99_2.htm)\n\n \n\n \n\n \n\n104\n\nThe cover page from this Current Report on Form 8-K, formatted in Inline XBRL.\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\nREGENXBIO INC.\n\n \n\n \n\n \n\n \n\nDate:\n\nMay 14, 2026\n\nBy:\n\n/s/ Patrick J. Christmas II\n\n \n\n \n\n \n\nPatrick J. Christmas II\n\nExecutive Vice President, Chief Strategy & Legal Officer"}